This company is really a long shot. With the minimal resources can it really get thru Phase 1,2 and 3 trials successfully and passed the FDA. Much hyped but unfortunately at least 10-15 years to go and that's if it is succesfull. During Covid they seemed to give the mpression they were alot closer but they aren't close at all. Infact they are not in the ball park. Stupid money went into this company like many others during Covid and I recall share price even was in the high twenties. How things have changed.
Ann: Cholesterol-Lowering Program Preclinical Studies Completed, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $69.60M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.3¢ | 32.5¢ | $195.9K | 589.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14970 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 20100 | 1 |
View Market Depth
| Last trade - 15.29pm 25/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |